Activation and evasion of type I interferon responses by SARS-CoV-2

Lei, Xiaobo; Dong, Xiaojing; Ma, Ruiyi; Wang, Wenjing; Xiao, Xia; Tian, Zhongqin; Wang, Conghui; Wang, Ying; Li, Li; Ren, Lili; Guo, Fei; Zhao, Zhendong; Zhou, Zhuo; Xiang, Zichun; Wang, Jianwei

The pandemic of COVID-19 has posed an unprecedented threat to global public health. However, the interplay between the viral pathogen of COVID-19, SARS-CoV-2, and host innate immunity is poorly understood. Here we show that SARS-CoV-2 induces overt but delayed type-I interferon (IFN) responses. By screening 23 viral proteins, we find that SARS-CoV-2 NSP1, NSP3, NSP12, NSP13, NSP14, ORF3, ORF6 and M protein inhibit Sendai virus-induced IFN-β promoter activation, whereas NSP2 and S protein exert opposite effects. Further analyses suggest that ORF6 inhibits both type I IFN production and downstream signaling, and that the C-terminus region of ORF6 is critical for its antagonistic effect. Finally, we find that IFN-β treatment effectively blocks SARS-CoV-2 replication. In summary, our study shows that SARS-CoV-2 perturbs host innate immune response via both its structural and nonstructural proteins, and thus provides insights into the pathogenesis of SARS-CoV-2.